Lysine-specific demethylase 1 (LSD1) participate in porcine early embryonic development by regulating cell autophagy and apoptosis through the mTOR signaling pathway

被引:1
|
作者
Qi, Jiajia [1 ]
Zhang, Shaoxuan [1 ]
Qu, Hexuan [1 ]
Wang, Yanqiu [1 ]
Dong, Yanwei [1 ]
Wei, Huakai [1 ]
Wang, Yu [1 ]
Sun, Boxing [1 ]
Jiang, Hao [1 ]
Zhang, Jiabao [1 ]
Liang, Shuang [1 ]
机构
[1] Jilin Univ, Coll Anim Sci, Dept Anim Sci, Changchun, Jilin, Peoples R China
关键词
Porcine early embryonic development; LSD1; Autophagy; CANCER-CELLS; INHIBITION; EXPRESSION; METABOLISM; ACTIVATION; HOMOLOG;
D O I
10.1016/j.theriogenology.2024.05.010
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Lysine-specific demethylase 1 (LSD1) stands as the pioneering histone demethylase uncovered, proficient in demethylating H3K4me1/2 and H3K9me1/2, thereby governing transcription and participating in cell apoptosis, proliferation, or differentiation. Nevertheless, the complete understanding of LSD1 during porcine early embryonic development and the underlying molecular mechanism remains unclear. Thus, we investigated the mechanism by which LSD1 plays a regulatory role in porcine early embryos. This study revealed that LSD1 inhibition resulted in parthenogenetic activation (PA) and in vitro fertilization (IVF) embryo arrested the development, and decreased blastocyst quality. Meanwhile, H3K4me1/2 and H3K9me1/2 methylase activity was increased at the 4-cell embryo stage. RNA-seq results revealed that autophagy related biological processes were highly enriched through GO and KEGG pathway analyses when LSD1 inhibition. Further studies showed that LSD1 depletion in porcine early embryos resulted in low mTOR and p-mTOR levels and high autophagy and apoptosis levels. The LSD1 deletion-induced increases in autophagy and apoptosis could be reversed by addition of mTOR activators. We further demonstrated that LSD1 inhibition induced mitochondrial dysfunction and mitophagy. In summary, our research results indicate that LSD1 may regulate autophagy and apoptosis through the mTOR pathway and affect early embryonic development of pigs.
引用
收藏
页码:119 / 133
页数:15
相关论文
共 50 条
  • [41] Lysine-Specific Demethylase 1 (LSD1) Is Required for the Transcriptional Repression of the Telomerase Reverse Transcriptase (hTERT) Gene
    Zhu, Qingjun
    Liu, Cheng
    Ge, Zheng
    Fang, Xiaolei
    Zhang, Xi
    Straat, Klas
    Bjorkholm, Magnus
    Xu, Dawei
    PLOS ONE, 2008, 3 (01):
  • [42] The Epigenetic Controller Lysine-Specific Demethylase 1 (LSD1) Regulates the Outcome of Hepatitis C Viral Infection
    Papadopoulou, Georgia
    Petroulia, Stavroula
    Karamichali, Eirini
    Dimitriadis, Alexios
    Marousis, Dimitrios
    Ioannidou, Elisavet
    Papazafiri, Panagiota
    Koskinas, John
    Foka, Pelagia
    Georgopoulou, Urania
    CELLS, 2023, 12 (21)
  • [43] Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc
    Nagasaka, Mai
    Tsuzuki, Kaori
    Ozeki, Yu
    Tokugawa, Muneshige
    Ohoka, Nobumichi
    Inoue, Yasumichi
    Hayashi, Hidetoshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 481 - 488
  • [44] Evaluation of in vitro and in vivo efficacy of pharmacological lysine-specific demethylase 1 (LSD1) inhibitors in glioblastoma stem cell (GSC) models
    Stitzlein, Lea
    Gangadharan, Achintyan
    Grasse, Leslie
    Espejo, Alexsandra
    Singh, Melissa
    Lu, Yue
    Ezhilarasan, Ravesanker
    Gumin, Joy
    Sulman, Erik
    Lang, Frederick
    Chandra, Joya
    FASEB JOURNAL, 2022, 36
  • [45] Phase 3 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with essential thrombocythemia (ET).
    Volchek, Yulia
    Zimran, Eran
    Kirgner, Ilya
    Yin, Lina
    Yusuf, Rushdia
    Gumuscu, Burak
    Ross, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1A (LSD1) SUPPORTS HUMAN HSCS IN CULTURE BY PRESERVING THEIR IMMATURE STATE
    Subramaniam, Agatheeswaran
    Zemaitis, Kristijonas
    Talkhoncheh, Mehrnaz Safaee
    Debnath, Shubhranshu
    Chen, Jun
    Jain, Mayur
    Galeev, Roman
    Larsson, Jonas
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S87 - S87
  • [47] Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
    Amente, Stefano
    Milazzo, Giorgio
    Sorrentino, Maria Cristina
    Ambrosio, Susanna
    Di Palo, Giacomo
    Lania, Luigi
    Perini, Giovanni
    Majello, Barbara
    ONCOTARGET, 2015, 6 (16) : 14572 - 14583
  • [48] Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in patients with polycythemia vera (PV).
    Rinaldi, Ciro
    Rein, Lindsay
    Livings, Alice
    Innes, Andrew J.
    Pettit, Kristen
    Yeh, Paul
    Larsen, Stephen R.
    Watson, Anne-Marie
    Leahy, Michael F.
    Curto-Garcia, Natalia
    Mahdi, Ali
    Frewin, Rebecca
    Qureshi, Haifz
    Shatzel, Joseph
    Vaughn, Jennifer
    Tashi, Tsewang
    Amin, Harshad
    Ogbu, Uzor
    Gumuscu, Burak
    Ross, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Lysine-specific demethylase 1 (LSD1) suppresses cellular senescence by riboflavin uptake-dependent demethylation activity
    Osumi, Taiichi
    Nagano, Taiki
    Iwasaki, Tetsushi
    Nakanishi, Jotaro
    Miyazawa, Kazuyuki
    Kamada, Shinji
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [50] Inhibition of Lysine-Specific Demethylase 1A (LSD1) Supports Human HSCs in Culture By Preserving Their Immature State
    Subramaniam, Agatheeswaran
    Talkhoncheh, Mehrnaz Safaee
    Zemaitis, Kristijonas
    Debnath, Shubhranshu
    Chen, Jun
    Jain, Mayur
    Galeev, Roman
    Larsson, Jonas
    BLOOD, 2018, 132